ROCs analysis for definition of optimal cutoffs for protection from recurrent infection
. | CD4+, % . | . | . | . | CD8+, % . | . | . | . | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cutoff* . | Sens . | Spec . | PPV . | NPV . | Sens . | Spec . | PPV . | NPV . | ||||||
| 0.4 | 100 | 80 | 97 | 100 | 100 | 60 | 94 | 100 | ||||||
| 1.0 | 97 | 100 | 100 | 83 | 100 | 80 | 97 | 100 | ||||||
| 3.0 | 44 | 100 | 100 | 21 | 100 | 100 | 100 | 83 | ||||||
| 5.0 | 26 | 100 | 100 | 17 | 82 | 100 | 100 | 45 | ||||||
| 7.0 | 26 | 100 | 100 | 17 | 70 | 100 | 100 | 33 | ||||||
| 10.0 | 15 | 100 | 100 | 15 | 58 | 100 | 100 | 26 | ||||||
. | CD4+, % . | . | . | . | CD8+, % . | . | . | . | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cutoff* . | Sens . | Spec . | PPV . | NPV . | Sens . | Spec . | PPV . | NPV . | ||||||
| 0.4 | 100 | 80 | 97 | 100 | 100 | 60 | 94 | 100 | ||||||
| 1.0 | 97 | 100 | 100 | 83 | 100 | 80 | 97 | 100 | ||||||
| 3.0 | 44 | 100 | 100 | 21 | 100 | 100 | 100 | 83 | ||||||
| 5.0 | 26 | 100 | 100 | 17 | 82 | 100 | 100 | 45 | ||||||
| 7.0 | 26 | 100 | 100 | 17 | 70 | 100 | 100 | 33 | ||||||
| 10.0 | 15 | 100 | 100 | 15 | 58 | 100 | 100 | 26 | ||||||
Sens indicates sensitivity; Spec, specificity; PPV, positive predictive value; and NPV, negative predictive value.
T cells per μL.